Provided by Tiger Trade Technology Pte. Ltd.

Silexion Therapeutics Corp

0.2349
-0.0187-7.37%
Post-market: 0.2270-0.0079-3.36%19:50 EDT
Volume:1.51M
Turnover:354.45K
Market Cap:3.40M
PE:0.00
High:0.2499
Open:0.2460
Low:0.2220
Close:0.2536
52wk High:42.00
52wk Low:0.2220
Shares:14.47M
Float Shares:14.47M
Volume Ratio:0.88
T/O Rate:10.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-56.4473
EPS(LYR):-89.5962
ROE:-897.46%
ROA:-123.27%
PB:77.27
PE(LYR):0.00

Loading ...

Silexion Therapeutics Announces First Patient Successfully Dosed in Phase 2/3 Clinical Trial of Sil204 in Locally Advanced Pancreatic Cancer

THOMSON REUTERS
·
Sep 30

Silexion Therapeutics Says Holders Exercise Warrants for 3,216,928 Shares at $0.2603 Each

Reuters
·
Sep 29

Silexion Therapeutics Announces Exercise of Warrants

GlobeNewswire
·
Sep 29

Silexion Says Sil204 Uses Native Serum Lipids for Cellular Uptake, Boosts KRAS Knockdown in Preclinical Study

Reuters
·
Sep 28

Silexion Therapeutics Corp - Serum Lipid Depletion Significantly Reduces Sil204 Gene-Knockdown Efficiency

THOMSON REUTERS
·
Sep 28

Silexion Therapeutics Corp - Sil204 Achieves Robust Gene Silencing in Kras Cancer Cells with Physiological Serum Lipids

THOMSON REUTERS
·
Sep 28

Silexion Therapeutics Reports Positive Preclinical Findings for Sil204, Demonstrating Key Mechanism for Endogenous Systemic Uptake in Kras-Driven Cancers

THOMSON REUTERS
·
Sep 28

Silexion Therapeutics Extraordinary Meeting Again Lacks Quorum, Proceeds Under Articles of Association

Reuters
·
Sep 26

U.S. Stocks on the MOVE-Greenland Mines, GameStop, Shopify

Reuters
·
Sep 22

Silexion Therapeutics to Participate in September 2026 Industry and Investor Conferences

GlobeNewswire
·
Sep 09

After Moderna’s $44B Oncology Win, Silexion’s Pancreatic Cancer Treatment is Worth Exploring (NASDAQ: SLXN)

TIPRANKS
·
Aug 25

Silexion Therapeutics Announces Extraordinary Shareholder Meeting

Reuters
·
Aug 25

Silexion Therapeutics Faces NASDAQ Delisting Notice over Minimum Shareholders’ Equity Shortfall

Reuters
·
Aug 22

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Atai Beckley N.V. (ATAI), InspireMD (NSPR) and Silexion Therapeutics (SLXN)

TIPRANKS
·
Aug 20

Silexion Therapeutics Announces Extraordinary General Meeting

Reuters
·
Aug 15

Silexion Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
Aug 14

U.S. Stocks on the MOVE-Sutro Biopharma, Humacyte

Reuters
·
Aug 13

Top Premarket Decliners

MT Newswires Live
·
Aug 12

Silexion Therapeutics Prices USD 2.5 Million Public Offering at USD 0.65 Per Share with Warrants

Reuters
·
Aug 12

Silexion Therapeutics Announces Pricing of $2.5 Million Public Offering

THOMSON REUTERS
·
Aug 12